Agilent Launches Biopharma CDx Services Lab to Accelerate Precision Medicine
The BCSL and Agilent’s assay development model will support drug development from early clinical studies through regulatory approval with efficient, flexible, and streamlined companion diagnostic development.
Biopharma CDx Services Lab | 10/09/2024 | By Aishwarya | 118
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy